510(k) device
VIA360 Surgical System
New World Medical, Inc. · Pump, Infusion, Ophthalmic (MRH, Class II) · First FDA decision Feb 14, 2025, newest Feb 14, 2025Glaucoma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "VIA360"
MAUDE reports
18
Brand "VIA360", since 2015
PubMed studies
1
Mentioning "VIA360"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing VIA360 Surgical System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- VIA360 Surgical System510(k)
K243503 · Decided Feb 14, 2025 · 94 days after receipt
Device type: Pump, Infusion, Ophthalmic (MRH) · Hospital Medicine & Nursing
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "VIA360", any status and sponsor, newest update first.
No registered device study names "VIA360".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "VIA360", and for the whole product code for context.
This brand
18 reports: 0 malfunction, 18 injury, 0 death
Whole product code MRH
140 reports: 44 malfunction, 95 injury, 0 death
Newest reports for this brand
- VIA360 Surgical SystemInjury
1000125279-2026-00032 · Received Aug 24, 2026
Device type: Trabeculotome (HMZ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hyphema
- VIA360 Surgical SystemInjury
1000125279-2026-00033 · Received Aug 24, 2026
Device type: Trabeculotome (HMZ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hyphema
- VIA360 Surgical SystemInjury
1000125279-2026-00030 · Received Jul 27, 2026 · Event dated Jun 29, 2026
Device type: Trabeculotome (HMZ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding; Hyphema
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "VIA360"[tiab]. The summary above synthesizes these.
- Early Safety and Efficacy Outcomes of a Novel 360° Canaloplasty Device in Open-Angle Glaucoma: A Retrospective Cohort Study.
Shi KSY, Dorairaj EA, Wang M, et al. · Clin Ophthalmol · 2026
Other devices of this type
Also filed under product code MRH.
- OMNI Surgical SystemSight Sciences, Inc. · 510(k) 2023
- Viscoelastic InjectorSight Sciences, Inc. · 510(k) 2014
- OMNI Ultra Surgical System (1-110)Sight Sciences, Inc. · 510(k) 2026
- TrabEx ProMicrosurgical Technologies, Inc. · 510(k) 2022
- iPrime Viscodelivery SystemGlaukos · 510(k) 2022
- Streamline Surgical SystemNew World Medical, Inc. · 510(k) 2021
- OMNI PLUS Surgical SystemSight Sciences, Inc. · 510(k) 2020
- VISCO 360 Viscosurgical SystemSight Sciences, Inc. · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.